PP
BPMC
PDT Partners’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Buy |
34,271
+28,173
| +462% | +$3.61M | 0.25% | 139 |
|
|
2025
Q1 | $540K | Buy |
6,098
+3,000
| +97% | +$266K | 0.04% | 513 |
|
|
2024
Q4 | $270K | Buy |
+3,098
| New | +$270K | 0.02% | 602 |
|
|
2024
Q2 | – | Sell |
-15,129
| Closed | -$1.44M | – | 668 |
|
|
2024
Q1 | $1.44M | Sell |
15,129
-4,398
| -23% | -$417K | 0.14% | 257 |
|
|
2023
Q4 | $1.8M | Sell |
19,527
-3,641
| -16% | -$336K | 0.2% | 171 |
|
|
2023
Q3 | $1.16M | Sell |
23,168
-26
| -0.1% | -$1.31K | 0.15% | 248 |
|
|
2023
Q2 | $1.47M | Buy |
23,194
+9
| +0% | +$569 | 0.2% | 176 |
|
|
2023
Q1 | $1.04M | Sell |
23,185
-5,933
| -20% | -$267K | 0.14% | 250 |
|
|
2022
Q4 | $1.28M | Buy |
29,118
+11,170
| +62% | +$489K | 0.21% | 176 |
|
|
2022
Q3 | $1.18M | Buy |
+17,948
| New | +$1.18M | 0.18% | 173 |
|
|
2022
Q2 | – | Sell |
-3,874
| Closed | -$247K | – | 969 |
|
|
2022
Q1 | $247K | Buy |
+3,874
| New | +$247K | 0.02% | 773 |
|
|
2021
Q2 | – | Sell |
-46,000
| Closed | -$4.47M | – | 807 |
|
|
2021
Q1 | $4.47M | Sell |
46,000
-8,918
| -16% | -$867K | 0.32% | 90 |
|
|
2020
Q4 | $6.16M | Sell |
54,918
-9,582
| -15% | -$1.07M | 0.42% | 51 |
|
|
2020
Q3 | $5.98M | Sell |
64,500
-4,531
| -7% | -$420K | 0.39% | 98 |
|
|
2020
Q2 | $5.38M | Sell |
69,031
-26,596
| -28% | -$2.07M | 0.37% | 113 |
|
|
2020
Q1 | $5.59M | Buy |
95,627
+34,627
| +57% | +$2.02M | 0.44% | 85 |
|
|
2019
Q4 | $4.89M | Buy |
61,000
+3,300
| +6% | +$264K | 0.3% | 115 |
|
|
2019
Q3 | $4.24M | Buy |
57,700
+40
| +0.1% | +$2.94K | 0.25% | 128 |
|
|
2019
Q2 | $5.44M | Buy |
+57,660
| New | +$5.44M | 0.32% | 106 |
|